Medical Use
Soliris is a complement inhibitor prescribed for:
- -Reducing hemolysis in patients with paroxysmal nocturnal hemoglobinuria (PNH).
- -Inhibiting complement-mediated thrombotic microangiopathy in patients with atypical hemolytic uremic syndrome (aHUS).
Warning & Precautions
Patients receiving Soliris should be closely monitored for early signs and symptoms of meningococcal infection, and any suspected infections should be promptly assessed. Exercise caution when administering eculizumab injections to patients with any systemic infections.
After discontinuing eculizumab, patients should be monitored for at least 8 weeks to detect any signs of hemolysis. If patients experience severe infusion reactions while using Soliris, the injection should be interrupted, and appropriate medical therapy should be provided.
Documentation Availability
Documents required to import SOLIRIS to India?
SOLIRIS (Eculizumab) can be imported by patients or treating physicians on behalf of patients. The following documentation is required to import the product:
- (i)2 ID proofs along with PAN card details along with attested scanned copies
- (ii)Valid doctor prescription scanned copy
- (iii)Doctor’s MCI number
- (iv)Doctor’s mobile number
- (v)Patients diagnostic reports
How is the order confirmed?
The order will be confirmed only after the receipt of:
- (i)The above-mentioned documents and drug availability.
- (ii)Import permit if applicable.
Sourcing & Delivery
The Rx4U team has extensive experience in sourcing SOLIRIS (Cancer Treatment Medicines around the world, ensuring global access to the best available treatments for our customers. We are dedicated to promptly dispensing any valid prescription. All prescriptions are verified and dispatched directly to the patient’s address. Our patients are our top priority, and we strive to improve their lives through our services.
FAQ
What is the generic name for the trade name drug Soliris®?
The generic name for Soliris® is Eculizumab.
Who manufactures Soliris®?
Soliris® is manufactured by Alexion, Inc.
Is Soliris® approved by the FDA?
Yes, Soliris® was approved by the FDA on September 23, 2011.
What is the dosage and form in which Soliris® is available?
Soliris® is available in 300 mg single-use vials, each containing 30 mL of a 10 mg/mL sterile, preservative-free solution.
How to order Soliris® online in India?
Soliris® can be ordered online in India through https://rx4u.in/.
*Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and Rx4U does not lay any claim on them we only provide Information.
